硫代硫酸钠在钙化防御中的机制和临床应用
The Mechanism and Clinical Application of Sodium Thiosulfate in Treatment of Calciphylaxis
DOI: 10.12677/ACM.2021.1112920, PDF,    国家自然科学基金支持
作者: 胡莞芊, 郁胜强*：海军军医大学第二附属医院肾内科，上海
关键词: 硫代硫酸钠；钙化防御；血管钙化；作用机制；临床应用；Sodium Thiosulfate； Calciphylaxis； Vascular Calcification； Mechanisms； Clinical Application
摘要: 钙化防御，又名钙性尿毒症性小动脉病(calcific uremic arteriopathy, CUA)，是一种发生于终末期肾脏病患者中的罕见的、致死性高的血管钙化性疾病，其早期临床症状不典型，预后差，且缺乏明确的临床指南。目前，在临床上，对于钙化防御的治疗主要是采用以硫代硫酸钠(Sodium thiosulfate, STS)为主的综合治疗。硫代硫酸钠治疗钙化防御主要通过钙螯合、抗氧化应激、酸中毒、舒张血管和抗炎镇痛作用及钙化抑制因子作用等机制，而随着临床研究的进展，关于这些治疗机制尚存在一些争议。
Abstract: Calciphylaxis, also known as calcium uremic arteriosis, is a special vascular calcification in patients with end-stage kidney disease which has atypical early clinical symptoms, poor prognosis, and unclear clinical guidelines. At present, sodium thiosulfate (STS) is the most commonly recommended drug in treatment of calciphylaxis which plays a role mainly through the mechanisms of calcium chelation, antioxidant stress, acidosis, vasodilation, anti-inflammatory and analgesic effects, and calcification inhibitors. However, there are still some controversies about these therapeutic mechanisms with the progress of clinical research.
文章引用：胡莞芊, 郁胜强. 硫代硫酸钠在钙化防御中的机制和临床应用[J]. 临床医学进展, 2021, 11(12): 6201-6206. https://doi.org/10.12677/ACM.2021.1112920

参考文献

[1] Ingelfinger, J.R., Nigwekar, S.U., Thadhani, R., et al. (2018) Calciphylaxis. New England Journal of Medicine, 378, 1704-1714. [Google Scholar] [CrossRef] 
[2] 张晓良, 刘玉秋, 刘必成. 钙化防御早期诊治进展[J]. 内科理论与实践, 2018, 13(4): 212-217. [Google Scholar] [CrossRef] 
[3] 杨璨粼, 刘玉秋. 透析患者钙化防御的治疗[J]. 肾脏病与透析肾移植杂志, 2019, 28(6): 580-585. [Google Scholar] [CrossRef] 
[4] O’neill, W.C. and Lomashvili, K.A. (2010) Recent Progress in the Treatment of Vascular Calcification. Kidney International, 78, 1232-1239. [Google Scholar] [CrossRef] [PubMed]
[5] Brandenburg, V.M., Sinha, S., Torregrosa, J.V., et al. (2019) Improvement in Wound Healing, Pain, and Quality of Life after 12 Weeks of SNF472 Treatment: A Phase 2 Open-Label Study of Patients with Calciphylaxis. Journal of Nephrology, 32, 811-821. [Google Scholar] [CrossRef] [PubMed]
[6] Peng, T., Zhuo, L., Wang, Y., et al. (2018) Systematic Review of Sodium Thiosulfate in Treating Calciphylaxis in Chronic Kidney Disease Patients. Nephrology (Carlton), 23, 669-675. [Google Scholar] [CrossRef] [PubMed]
[7] Saengpanit, D., Chattranukulchai, P., Tumkosit, M., et al. (2018) Effect of Sodium Thiosulfate on Arterial Stiffness in End-Stage Renal Disease Patients Undergoing Chronic Hemodialysis (Sodium Thiosulfate-Hemodialysis Study): A Randomized Controlled Trial. Nephron, 139, 219-227. [Google Scholar] [CrossRef] [PubMed]
[8] 邢婕, 张晓良, 谢筱彤, 等. 内脏钙化防御合并重度铁过载一例[J]. 中华肾脏病杂志, 2020, 36(2): 150-153. [Google Scholar] [CrossRef] 
[9] Hayden, M.R. and Dj, G. (2010) Sodium Thiosulfate: New Hope for the Treatment of Calciphylaxis. Seminars in Dialysis, 23, 258-262. [Google Scholar] [CrossRef] 
[10] Pasch, A., Schaffner, T., Huynh-Do, U., et al. (2008) Sodium Thiosulfate Prevents Vascular Calcifications in Uremic Rats. Kidney International, 74, 1444-1453. [Google Scholar] [CrossRef] [PubMed]
[11] O’Neill, W.C. and Ki, H. (2012) The Chemistry of Thiosulfate and Vascular Calcification. Nephrology Dialysis Transplantation, 27, 521-526. [Google Scholar] [CrossRef] [PubMed]
[12] Vashistha, T., Kalantar-Zadeh, K., Molnar, M.Z., et al. (2013) Dialysis Modality and Correction of Uremic Metabolic Acidosis: Relationship with All-Cause and Cause-Specific Mortality. Clinical Journal of the American Society of Nephrology, 8, 254-264. [Google Scholar] [CrossRef] 
[13] Mendoza, F.J., Lopez, I., Montes de Oca, A., et al. (2008) Metabolic Acidosis Inhibits Soft Tissue Calcification in Uremic Rats. Kidney International, 73, 407-414. [Google Scholar] [CrossRef] [PubMed]
[14] Solis, A.J.D., González-Pacheco, F.R., Deudero, J.J.P., et al. (2009) Alkalinization Potentiates Vascular Calcium Deposition in an Uremic Milieu. Journal of Nephrology, 22, 647-653.
[15] Chen, N.X., Kircelli, F., O’neill, K.D., et al. (2010) Verapamil Inhibits Calcification and Matrix Vesicle Activity of Bovine Vascular Smooth Muscle Cells. Kidney International, 77, 436-442. [Google Scholar] [CrossRef] [PubMed]
[16] Liu, H., Li, X., Qin, F., et al. (2014) Selenium Suppresses Oxidative-Stress-Enhanced Vascular Smooth Muscle Cell Calcification by Inhibiting the Activation of the PI3K/AKT and ERK Signaling Pathways and Endoplasmic Reticulum Stress. Journal of Biological Inorganic Chemistry, 19, 375-388. [Google Scholar] [CrossRef] [PubMed]
[17] Ralf, S. (2004) Causes and Therapy of Microinflammation in Renal Failure. Nephrology Dialysis Transplantation, 19, V34-V40. [Google Scholar] [CrossRef] [PubMed]
[18] Oka, M., Ohtake, T., Mochida, Y., et al. (2012) Correlation of Coronary Artery Calcification with Pre-Hemodialysis Bicarbonate Levels in Patients on Hemodialysis. Therapeutic Apheresis and Dialysis, 16, 267-271. [Google Scholar] [CrossRef] [PubMed]
[19] Selk, N. and Rodby, R.A. (2015) Unexpectedly Severe Metabolic Acidosis Associated with Sodium Thiosulfate Therapy in a Patient with Calcific Uremic Arteriolopathy. Seminars in Dialysis, 24, 85-88. [Google Scholar] [CrossRef] 
[20] Hunt, G.M. and Ryder, H.F. (2018) Metabolic Acidosis after Sodium Thiosulfate Infusion and the Role of Hydrogen Sulfide. Clinical Case Reports, 6, 1595-1599. [Google Scholar] [CrossRef] [PubMed]
[21] Hundemer, G.L., Fenves, A.Z., Phillips, K.M., et al. (2016) Sodium Thiosulfate and the Anion Gap in Patients Treated by Hemodialysis. American Journal of Kidney Diseases, 68, 499-500. [Google Scholar] [CrossRef] [PubMed]
[22] Chao, C.T., Yeh, H.Y., Yt, T., et al. (2019) Natural and Non-Natural Antioxidative Compounds: Potential Candidates for Treatment of Vascular Calcification. Cell Death Discovery, 5, 145. [Google Scholar] [CrossRef] [PubMed]
[23] Nguyen, I.T.N., Klooster, A., Minnion, M., et al. (2020) Sodium Thiosulfate Improves Renal Function and Oxygenation in L-NNA-Induced Hypertension in Rats. Kidney International, 98, 366-377. [Google Scholar] [CrossRef] [PubMed]
[24] Gadalla, M.M. and Snyder, S.H. (2010) Hydrogen Sulfide as a Gasotransmitter. Journal of Neurochemistry, 113, 14-26. [Google Scholar] [CrossRef] [PubMed]
[25] Streeter, E., Ng, H.H. and Hart, J.L. (2013) Hydrogen Sulfide as a Vasculoprotective Factor. Medical Gas Research, 3, 9. [Google Scholar] [CrossRef] [PubMed]
[26] Zanardo, R.C., Brancaleone, V., Distrutti, E., et al. (2006) Hydrogen Sulfide Is an Endogenous Modulator of Leukocyte-Mediated Inflammation. The FASEB Journal, 20, 2118-2120. [Google Scholar] [CrossRef] [PubMed]
[27] Distrutti, E., Sediari, L., Mencarelli, A., et al. (2006) Evidence That Hydrogen Sulfide Exerts Antinociceptive Effects in the Gastrointestinal Tract by Activating KATP Channels. The Journal of Pharmacology and Experimental Therapeutics, 316, 325-335. [Google Scholar] [CrossRef] [PubMed]
[28] Whiteman, M., Li, L., Rose, P., et al. (2010) The Effect of Hydrogen Sulfide Donors on Lipopolysaccharide-Induced Formation of Inflammatory Mediators in Macrophages. Antioxidants & Redox Signaling, 12, 1147-1154. [Google Scholar] [CrossRef] [PubMed]
[29] Luo, G., Ducy, P., Mckee, M.D., et al. (1997) Spontaneous Calcification of Arteries and Cartilage in Mice Lacking Matrix GLA Protein. Nature, 386, 78-81. [Google Scholar] [CrossRef] [PubMed]
[30] Zhong, H., Liu, F., Dai, X., et al. (2013) Sodium Thiosulfate Protects Human Aortic Smooth Muscle Cells from Osteoblastic Transdifferentiation via High-Level Phosphate. The Kaohsiung Journal of Medical Sciences, 29, 587-593. [Google Scholar] [CrossRef] [PubMed]
[31] Brucculeri, M., Cheigh, J., Bauer, G., et al. (2015) Long-Term Intravenous Sodium Thiosulfate in the Treatment of a Patient with Calciphylaxis. Seminars in Dialysis, 18, 431-434. [Google Scholar] [CrossRef] 
[32] Isoherranen, K., Bouchard, L. and Kluger, N. (2017) Benefits of Intralesional Injections of Sodium Thiosulfate in the Treatment of Calciphylaxis. International Wound Journal, 14, 955-959. [Google Scholar] [CrossRef] [PubMed]
[33] Shetty, A. and Klein, J. (2016) Treatment of Calciphylaxis: A Case for Oral Sodium Thiosulfate. Advances in Peritoneal Dialysis, 32, 51-55.
[34] Mataic, D. and Bastani, B. (2006) Intraperitoneal Sodium Thiosulfate for the Treatment of Calciphylaxis. Renal Failure, 28, 361-363. [Google Scholar] [CrossRef] [PubMed]
[35] Gupta, D.R., Sangha, H. and Khanna, R. (2012) Chemical Peritonitis after Intraperitoneal Sodium Thiosulfate. Peritoneal Dialysis International, 32, 220-222. [Google Scholar] [CrossRef] [PubMed]
[36] Courtney, M.J. and Pannu, N. (2010) Calcific Uremic Arteriolopathy Should Be Treated Conservatively. Seminars in Dialysis, 23, 34-37. [Google Scholar] [CrossRef] 
[37] Shen, C., Zhou, Y., Chen, Z.X., et al. (2019) Hypercalcemia Associated with Sodium Thiosulfate Treatment in a Patient with Calciphylaxis. Polish Archives of Internal Medicine, 129, 638-640. [Google Scholar] [CrossRef] [PubMed]

为你推荐